Human α-defensin 5 suppressed colon cancer growth by targeting PI3K pathway

• DOI: 10.1016/j.yexcr.2021.112809
• Publication Date: 2021-09-03T14:48:12Z
• Authors: Qiao Qiao; Ruixia Bai; Wanying Song; Haining Gao; Minyu Zhang; Jingkun Lu; Mei Hong; Xuan Zhang; Peng Sun; Qian Zhang; Pengwei Zhao
• Keywords: 0301 basic medicine; alpha-Defensins; 0303 health sciences; Mice, Nude; Apoptosis; Prognosis; Xenograft Model Antitumor Assays; 3. Good health; Gene Expression Regulation, Neoplastic; Survival Rate; Mice; Phosphatidylinositol 3-Kinases; 03 medical and health sciences; Cell Movement; Colonic Neoplasms; Biomarkers, Tumor; Tumor Cells, Cultured; Animals; Humans; Female; Cell Proliferation

Defensins are highly conserved antimicrobial peptides, which ubiquitously expressed in different species. In addition to the functions in host defense, their aberrant expression have also been documented in cancerous tissue including breast cancer, lung caner and renal carcinoma etc. Whereas, roles of Defensin Alpha 5 (DEFA5) in colon cancer has not been explored. Bioinformatic analysis was used to study the expression of DEFA5 and its correlation with clinical outcomes; Western blot, qPCR, Co-immunoprecipitation, xenograft models were used to the study the molecular mechanism. Decreased expression of DEFA5 at protein level was observed in colon tissues. Colon cancer cell lines proliferation and colony formation capacity were significantly suppressed by DEFA5 overexpression. Moreover, in vivo tumor growth in nude mice was also suppressed by DEFA5 overexpression, suggesting a tumor suppressor role of DEFA5 in colon cancer. Mechanistically, DEFA5 directly binds to the subunits of PI3K complex, thus attenuates the downstream signaling transduction, leads to delayed cell growth and metastasis. Collectively, we concluded that DEFA5 showed an inhibitory effect in colon cancer cell growth and may serve as a potential tumor suppressor in colon cancer.